Fig. 8From: Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling3D structure of the prepared EGFR receptor (pdb id = 2ITO)Back to article page